From: Peripheral and neural correlates of self-harm in children and adolescents: a scoping review
Citation, Country | Type of Self-harm | Study Design | Specific Correlate |
---|---|---|---|
Peripheral Correlates | |||
Robbins, Alessi 1985 US [54] | Suicidality | Case-control | Circadian rhythm, hypothalamic pituitary adreanal (HPA) axis, cortisol |
Rosenthal et al. 1986 US [55] | Suicidality | Case-control | Circadian rhythm, HPA axis, cortisol |
Dahl et al. 1991a US [56] | Suicidality | Case-control | Circadian rhythm, HPA axis, cortisol |
Dahl et al. 1992a US [57] | Suicidality | Case-control | Circadian rhythm, HPA axis, cortisol |
Ghaziuddin et al. 2014 US [58] | Suicidality | Case-control | Reactivity, HPA axis, cortisol |
Young et al. 2010 Scotland [59] | Suicidality | Cross-sectional | Circadian rhythm, HPA axis, cortisol |
Pfeffer et al. 1991 US [60] | Suicidality | Cohort | Circadian rhythm, HPA axis, cortisol |
Giletta, et al. 2015 US [61] | Suicidality | Cohort | Reactivity, HPA axis, cortisol, predicting symptoms |
Eisenlohr-Moul et al. 2018 US [62] | Suicidality | Cohort | Reactivity, HPA axis, cortisol, predicting symptoms |
Reichl et al., 2016 Germany [63] | NSSI | Case-control | Circadian rhythm, HPA axis, cortisol |
Klimes-Dougan et al. 2019 U S[64] | NSSI | Case-control | Reactivity, HPA axis, cortisol |
Reichl, et al. 2019 Germany [65] | NSSI | Case-control | Circadian rhythm, Reactivity, HPA axis, cortisol |
Beauchaine et al. 2015 US [66] | Any self-harm | Case-control | Circadian rhythm, HPA axis, cortisol |
Plener et al. 2016 Germany [67] | Any self-harm | Cohort | Reactivity, HPA axis, cortisol |
Yang et al., 2019 Hungary [68] | Suicidality | Case-control | Reactivity autonomic nervous system (ANS), cardiovascular (CV) system |
Giletta et al., 2017 US [69] | Suicidality | Cohort | Reactivity, ANS, CV system, prediction symptoms |
Koenig et al. 2017a Germany [70] | NSSI | Case-control | Resting, ANS, CV system |
Crowell et al. 2005 US [51] | Any self-harm | Case-control | Resting & reactivity, ANS, CV system, skin conductance |
Crowell et al. 2012 US [71] | Any self-harm | Case-control | Resting & reactivity, ANS, skin conductance |
Wielgus et al. 2016 US [72] | Any self-harm | Cohort | Resting & reactivity, ANS, CV system, prediction symptoms |
Aldrich et al. 2018 US [73] | Any self-harm | Cohort | Reactivity, ANS, skin conductance, prediction symptoms |
Kaess et al. 2012 Germany [74] | NSSI | Case-control | Reactivity, HPA axis & ANS, cortisol, CV system |
Koenig et al. 2017b Germany [75] | NSSI | Case-control | Reactivity, HPA axis & ANS, cortisol, CV system |
Modai et al. 1989 Israel [76] | Suicidality | Case-control | Platelet serotonin function |
Ambrosini et al. 1992 US [77] | Suicidality | Case-control | Platelet serotonin function |
Pfeffer et al. 1998 US [78] | Suicidality | Case-control | Serotonin, precursor levels, platelet function |
Tyano et al. 2006 Israel [79] | Suicidality | Case-control | Serotonin levels |
Pine et al. 1995 US [80] | Suicidality | Cohort | Platelet serotonin function |
Clark et al. 2003 US [81] | Suicidality | Cohort | Precursor levels, prediction symptoms |
Crowell et al. 2005 US [51] | Any self-harm | Case-control | Serotonin levels |
Crowell et al. 2008 US [82] | Any self-harm | Case-control | Serotonin levels |
Dahl et al., 1990 US [83] | Suicidality | Case-control | Sleep characteristics |
Dahl et al. 1991b US [84] | Suicidality | Case-control | Sleep characteristics |
Emslie et al. 1994 US [85] | Suicidality | Case-control | Sleep characteristics |
McCracken et al. 1997 US [86] | Suicidality | Case-control | Sleep characteristics |
Boafo et al. 2019 Canada [87] | Suicidality | Case-control | Sleep characteristics |
Singareddy et al. 2013 US [88] | Suicidality | Cohort | Sleep characteristics |
Bilgiç et al. 2020 Turkey [89] | Suicidality | Case-control | Neurotrophin levels |
Falcone et al. 2010 US [52] | Suicidality | Case-control | S100 calcium-binding protein B (S100B) levels |
Falcone et al. 2015 US [90] | Suicidality | Case-control | S100B levels |
Kavurma et al. 2017 Turkey [91] | Any self-harm | Case-control | Neurotrophin levels |
Gabbay et al. 2009 US [92] | Suicidality | Case-control | Cytokine levels |
Falcone et al. 2010 US (supplement data )[52] | Suicidality | Case-control | Cytokine levels |
Amitai et al. 2020 Israel [93] | Suicidality | Non-controlled pre-post intervention | Cytokine levels, predicting side effects |
Glueck et al. 1994 US [94] | Suicidality | Case-control | Lipid levels |
Plana et al. 2010 Spain [95] | Suicidality | Case-control | Lipid levels |
Ryan et al. 1988 US [96] | Suicidality | Case-control | Reactivity, growth hormone |
Dahl et al.1992b US [97] | Suicidality | Case-control | Circadian rhythm, growth hormone |
Neural Correlates | |||
Pan et al. 2011 US [98] | Suicidality | Case-control | Brain activity, response inhibition |
Pan et al. 2013a US [53] | Suicidality | Case-control | Brain activity, facial emotion processing |
Pan et al. 2013b US [99] | Suicidality | Case-control | Brain activity, decision-making |
Quevedo et al. 2016a US [100] | Suicidality | Case-control | Brain activity, emotion self-identity |
Harms et al. 2019 US [101] | Suicidality | Case-control | Brain activity, social interaction |
Oppenheimer et al. 2020 US [102] | Suicidality | Case-control | Brain activity, social interaction |
Plener et al. 2012 Germany [103] | NSSI | Case-control | Brain activity, emotion processing |
Groschwitz et al. 2016 Germany [104] | NSSI | Case-control | Brain activity, social interaction |
Quevdo et al. 2016b US [105] | NSSI | Case-control | Brain activity, emotion self-identity |
Brown et al. 2017 Germany [106] | NSSI | Case-control | Brain activity, social interaction |
Perini et al. 2019 Sweden [107] | NSSI | Case-control | Brain activity, social interaction |
Poon et al. 2019 US [108] | NSSI | Cross-sectional | Brain activity, reward processing |
Sauder et al., 2016 US [109] | Any self-harm | Case-control | Brain activity, reward processing |
Pan et al. 2013a US [53] | Suicidality | Case-control | Functional connectivity, facial emotion processing |
Alarcon et al. 2019 US [110] | Suicidality | Case-control | Functional connectivity, emotion self-identity |
Ordaz et al. 2018 US [111] | Suicidality | Cross-sectional | Functional connectivity, resting state |
Schreiner al. 2018 US [112] | Suicidality | Cross-sectional | Functional connectivity, resting state |
Schwartz et al. 2019 US [113] | Suicidality | Cohort | Functional connectivity, resting state, predicting symptom change |
Santamarina-Perez et al. 2019 US [114] | NSSI | Cohort | Functional connectivity, resting state, predicting treatment effect |
Tavakoli et al. 2018 Canada [115] | Suicidality | Case-control | Event-related potential, attention capture |
Tsypes, et al. 2019 US [116] | Suicidality | Case-control | Event-related potential, reward-loss |
Pegg et al. 2020 US [117] | Suicidality | Case-control | Event-related potential, reward-loss |
Tsypes et al. 2018 US [118] | NSSI | Case-control | Event-related potential, reward-loss |
Graae et al. 1996 US [119] | Suicidality | Case-control | Resting state, brain wave asymmetry |
Lewis et al. 2019 US [120] | Suicidality | Non-controlled pre-post intervention | Reactive intracortical inhibition, post-treatment |
Ho et al. 2018 US [121] | Suicidality | Cohort | Gray matter volume, predicting symptoms |
Ando et al. 2018 Germany [122] | NSSI | Case-control | Gray matter volume |
Beauchaine, et al. 2019 US [123] | Any self-harm | Case-control | Gray matter volume |
Pan et al., 2015 US [124] | Suicidality | Case-control | Gray, white matter volumes |
Goodman et al. 2011 US [125] | Any self-harm | Case-control | Gray and white matter volumes |
Jovev et al. 2008 US [126] | Any self-harm | Cross-sectional | Pituitary gland volume |